pharmaceutical companies

Overcoming the Biosimilar Bottleneck: The Solution to Medicine Shortages in Europe

🔍 Supply chain shortages in Europe worsened by pharmaceutical companies not licensing biosimilars. 🌍 A pan-European license could improve access. 💡 UK regulator encourages innovation. ⚙️ QTL technology can increase availability.